Conference detail

Kyra Williams, kwilliams@smi-online.co.uk, 02078276012

SMi's 7th annual Pharmaceutical Microbiology UK conference will provide attendees essential indicators for Quality Assurance and Quality Control whilst presenting that latest information on protecting pharmaceutical and healthcare products from spoilage by microorganisms, and protecting patients and consumers. With both sterile and non-sterile products, the effects can range from discoloration to the potential for fatality.

This year's event will provide an in-depth overview of the function of the pharmaceutical microbiologist and what they need to know, from regulatory filing and GMP, to laboratory design and management, and risk assessment tools and techniques. These key aspects are discussed through a series of dedicated presentations, keynote sessions and workshops, with topics covering biofilms, validation, data analysis, bioburden, toxins, microbial identification, mycoplasma testing, and contamination control.

Expert Speaker Line-Up Includes:

. Oliver Chancel, Sterility and Aseptic Process, Assurance Expert, Merial Sas

. Andrew Bartko, Research Leader, Battelle Memorial Institute

. Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna

. Ingo Spreitzer, Deputy Head Section Microbial Safety, Paul-Ehrlich Institute

. Ruth Daniels, Senior Scientist Microbiology, Janssen

. Jeremy Webb, Professor of Microbiology, Principal Investigator (Biofilms and Microbial Communities), University of Southampton

. Ian Symonds, Head Aseptic Intelligence and Strategy, GSK

. Shahram Lavasani, CEO and Founder, ImmuneBiotech

Exclusive highlights in 2017:

. Hear about new testing methods, like mycoplasma testing, to optimise contamination control

. Gain insight from a regulatory perspective on ways to make these testing methods compliant

. Hear about actual implementation of rapid microbial methods within a laboratory setting, that meet regulatory requirements